jeudi 7 avril 2016

Onco Actu du 7 avril 2016


4.9 Dép., diag. & prono. - Sein

New weapon against breast cancer [Harvard Gazette]

Systematic Review of Literature Further Validates that Breast Tomosynthesis Reduces False Positives and Increases Detection of Invasive Breast Cancer [Hologic]

5. Traitements

Science Talk - Are antibody-drug conjugates the fabled magic bullets against cancer? [The Institute of Cancer Research]

5.12 Immunothérapies

Immunotherapy and chemo combination shows early promise for pancreatic cancer [Cancer Research UK]

5.2.2 Pharma - Fusions & Acquisitions

The Treasury Wins Over Pfizer. Of Course. [In the Pipeline]

After failed Allergan merger, Pfizer once again considers splitting up the company [STAT]

Allergan Boss Brent Saunders On The Failed Pfizer Deal And Why He's Not Like Valeant [Forbes]

Merck CEO Ken Frazier Is Looking Smart For Avoiding A Tax Inversion [Forbes]

Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change [Reuters]

5.2.3 Pharma - économie

J&J grabs prostate cancer rights for Tesaro's niraparib in $500M deal [FierceBiotech]

5.3.4 Traitements - AMM (FDA, EMA)

European Commission Approves Expanded Use of Opdivo® (nivolumab) to Include Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer [BMS]

European Commission Approves Bristol-Myers Squibb’s Opdivo® (nivolumab) for Previously Treated Advanced Renal Cell Carcinoma [BMS]

5.4 Traitements - Economie

Amgen balks over meeting to review cost of bone cancer drugs [STAT]

JAMA Forum: We Can’t All Have It All: The Economic Limits of Pharmaceutical Innovation [news@JAMA]

5.9 AACR

Merck to Present New Data for KEYTRUDA® (pembrolizumab) at the American Association for Cancer Research 2016 Annual Meeting [Merck]

6.1 Observation

Study Shows Certain Gastrointestinal Tumors Associated with Higher Mortality [UCSD]

6.6 Publications

Does this scientific image look familiar? It's from a catalog [Retraction Watch]

6.7 DMP, Big Data & applis

Epic fail: Electronic health records make it difficult to tell patient stories [STAT]